PPD, Inc. Expands Post-Approval Drug Safety Capabilities through Strategic Alliance with WHISCON

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced it has expanded its post-approval drug safety expertise in epidemiology and risk management through a strategic alliance with World Health Information Science Consultants, LLC (WHISCON), an internationally recognized epidemiology and drug-safety organization based in Wellesley, Mass.

MORE ON THIS TOPIC